99 related articles for article (PubMed ID: 16906790)
1. Photodynamic activity of substituted zinc trisulfophthalocyanines: role of plasma membrane damage.
Cauchon N; Nader M; Bkaily G; van Lier JE; Hunting D
Photochem Photobiol; 2006; 82(6):1712-20. PubMed ID: 16906790
[TBL] [Abstract][Full Text] [Related]
2. Structure-photodynamic activity relationships of substituted zinc trisulfophthalocyanines.
Cauchon N; Tian H; Langlois R; La Madeleine C; Martin S; Ali H; Hunting D; van Lier JE
Bioconjug Chem; 2005; 16(1):80-9. PubMed ID: 15656578
[TBL] [Abstract][Full Text] [Related]
3. Photosensitization with zinc (II) phthalocyanine as a switch in the decision between apoptosis and necrosis.
Fabris C; Valduga G; Miotto G; Borsetto L; Jori G; Garbisa S; Reddi E
Cancer Res; 2001 Oct; 61(20):7495-500. PubMed ID: 11606385
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of mono-substituted trisulfonated porphyrazines for the photodynamic therapy (PDT) of cancer.
Cauchon N; Ali H; Hasséssian HM; van Lier JE
Photochem Photobiol Sci; 2010 Mar; 9(3):331-41. PubMed ID: 20221459
[TBL] [Abstract][Full Text] [Related]
5. P-glycoprotein does not reduce substrate concentration from the extracellular leaflet of the plasma membrane in living cells.
Chen Y; Pant AC; Simon SM
Cancer Res; 2001 Nov; 61(21):7763-9. PubMed ID: 11691790
[TBL] [Abstract][Full Text] [Related]
6. Y1068 phosphorylation is the most sensitive target of disulfonated tetraphenylporphyrin-based photodynamic therapy on epidermal growth factor receptor.
Weyergang A; Selbo PK; Berg K
Biochem Pharmacol; 2007 Jul; 74(2):226-35. PubMed ID: 17531956
[TBL] [Abstract][Full Text] [Related]
7. Variation in photodynamic efficacy during the cellular uptake of two phthalocyanine photosensitizers.
He J; Horng MF; Deahl JT; Oleinick NL; Evans HH
Photochem Photobiol; 1998 Jun; 67(6):720-8. PubMed ID: 9648537
[TBL] [Abstract][Full Text] [Related]
8. Cellular inactivation and antitumor efficacy of a new zinc phthalocyanine with potential use in photodynamic therapy.
Vittar NB; Prucca CG; Strassert C; Awruch J; Rivarola VA
Int J Biochem Cell Biol; 2008; 40(10):2192-205. PubMed ID: 18440266
[TBL] [Abstract][Full Text] [Related]
9. Biological activities of phthalocyanines. XVII histopathologic evidence for different mechanisms of EMT-6 tumor necrosis induced by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin.
Margaron P; Madarnas P; Quellet R; Van Lier JE
Anticancer Res; 1996; 16(2):613-20. PubMed ID: 8687105
[TBL] [Abstract][Full Text] [Related]
10. [Photodynamic therapy of zinc sulfonated phthalocyanine on murine transplanted tumors, its tissue distribution, and damaging effect on DNA of cancer cell].
Fu NW; Guo R; Yan LX; Huang L; Xu HJ
Zhongguo Yao Li Xue Bao; 1991 Sep; 12(5):457-61. PubMed ID: 1819903
[TBL] [Abstract][Full Text] [Related]
11. Effect of zinc insertion and hydrophobicity on the membrane interactions and PDT activity of porphyrin photosensitizers.
Pavani C; Uchoa AF; Oliveira CS; Iamamoto Y; Baptista MS
Photochem Photobiol Sci; 2009 Feb; 8(2):233-40. PubMed ID: 19247516
[TBL] [Abstract][Full Text] [Related]
12. Phase I clinical trial of the use of zinc phthalocyanine tetrasulfonate as a photosensitizer for photodynamic therapy in dogs.
Borgatti-Jeffreys A; Hooser SB; Miller MA; Lucroy MD
Am J Vet Res; 2007 Apr; 68(4):399-404. PubMed ID: 17397295
[TBL] [Abstract][Full Text] [Related]
13. Effect of sulfonation on the cell and tissue distribution of the photosensitizer aluminum phthalocyanine.
Chan WS; Marshall JF; Svensen R; Bedwell J; Hart IR
Cancer Res; 1990 Aug; 50(15):4533-8. PubMed ID: 2369730
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic properties of amphiphilic derivatives of aluminum tetrasulfophthalocyanine.
Allen CM; Langlois R; Sharman WM; La Madeleine C; Van Lier JE
Photochem Photobiol; 2002 Aug; 76(2):208-16. PubMed ID: 12194219
[TBL] [Abstract][Full Text] [Related]
15. Caspase-2: a possible trigger of apoptosis induced in A-549 tumor cells by ZnPc photodynamic treatment.
Cristóbal J; Stockert JC; Villanueva A; Rello-Varona S; Juarranz A; Cañete M
Int J Oncol; 2006 May; 28(5):1057-63. PubMed ID: 16596221
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy of malignant glioma with hypericin: comprehensive in vitro study in human glioblastoma cell lines.
Ritz R; Wein HT; Dietz K; Schenk M; Roser F; Tatagiba M; Strauss WS
Int J Oncol; 2007 Mar; 30(3):659-67. PubMed ID: 17273767
[TBL] [Abstract][Full Text] [Related]
17. Structural alterations induced by photodynamic action of hematoporphyrin derivative (HpD) in plasma membrane of glioblastoma (U-87MG) cells: time dependent fluorescence spectroscopic study.
Joshi K; Joshi PG; Joshi NB
Indian J Biochem Biophys; 1995 Aug; 32(4):200-6. PubMed ID: 8655188
[TBL] [Abstract][Full Text] [Related]
18. Selective photosensitizer delivery into plasma membrane for effective photodynamic therapy.
Kim J; Santos OA; Park JH
J Control Release; 2014 Oct; 191():98-104. PubMed ID: 24892975
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic and sonodynamic treatment by phthalocyanine on cancer cell lines.
Kolarova H; Tomankova K; Bajgar R; Kolar P; Kubinek R
Ultrasound Med Biol; 2009 Aug; 35(8):1397-404. PubMed ID: 19515482
[TBL] [Abstract][Full Text] [Related]
20. [Preferential tumoral phototoxicity of chloroaluminum phthalocyanine in photodynamic therapy of human leukemic cells].
Daziano JP; Humeau L; Chabannon C; Mannoni P; Julliard M
C R Seances Soc Biol Fil; 1995; 189(3):407-17. PubMed ID: 8521089
[No Abstract] [Full Text] [Related]
[Next] [New Search]
